*Please note the schedule is subject to change.
08:00-09:10 | Lessons Learned from Challenging Cases |
|
08:00-08:07 | Frequency of Eschar in Invasive Orbital Fungal Disease | Louise A Mawn (USA) | |
08:07-08:14 | Orbital Mucormycosis in Immunocompetent Patient Following SARS-CoV-2 Vaccination | Diego Strianese (Italy) | |
08:14-08:21 | Intraosseous Orbital Cavernous Hemangioma - Challenges in Its Management | Kasturi Bhattacharjee (India) | |
08:21-08:28 | The Management Approaches to Dacryoceles and Their Orbital Expansion | Pelin Kaynak (Turkey) | |
08:28-08:35 | Nasolacrimal Duct Obstruction in Patient with Meningoencephalocele: An Approach to Have A Successful Surgery | Yunia Irawati (Indonesia) | |
08:35-08:42 | Notorious Masses in and around the Orbit. Cases Discussion | Rohit Saiju (Nepal) | |
08:42-08:49 | Treatment of a Pediatric Case of Orbital Desmoid-type Fibromatosis with Sorafenib | Cat N Burkat (USA) | |
08:49-08:56 | Ophthalmic Manifestations and Visual Outcomes of Granulomatosis with Polyangiitis | Hokyung Choung (Korea) | |
08:56-09:10 | DISCUSSION |
09:10-10:25 | Thyroid Eye Disease 1 (Medical) |
|
09:10-09:20 | Thyroid Carcinoma and Thyroid Eye Disease | Lay Leng Seah (Singapore) | |
09:20-09:35 | Teprotumumab in the Treatment of TED | Raymond Douglas (USA) | |
09:35-09:45 | Thyroid Eye Disease with Compressive Optic Neuropathy: Visual Field Loss Classification and Nomenclature | Suzanne K Freitag (USA) | |
09:45-09:57 | Dysthyroid Optic Neuropathy | Peerooz Saeed (Netherlands) | |
09:57-10:04 | Novel Biomarkers in Thyroid Eye Disease | Jin Sook Yoon (Korea) | |
10:04-10:11 | Intraorbital Injections in the Management of TED | Essam El Toukhy (Egypt) | |
10:11-10:25 | DISCUSSION | ||
10:25-10:55 | BREAK |
10:55-11:45 | Thyroid Eye Disease 2 (Surgical) |
|
10:55-11:05 | Indication and Functional Outcome of Orbital Decompression in Thyroid Eye Disease | Christoph Hintschich (Germany) | |
11:05-11:15 | Optimizing Outcome of Orbital Decompression using Stereotactic Navigation | Reynaldo Javate (Philippines) | |
11:15-11:25 | Unbalanced Orbital Decompression | Milind Naik (India) | |
11:25-11:35 | Surgical Options for Deep Lateral Wall Decompression | Marco Sales-Sanz (Spain) | |
11:35-11:45 | DISCUSSION |
11:45-13:00 | Orbital Tumors 2 |
|
11:45-11:55 | Decision Trees in Management of Orbital Malignancy – Towards a Logical Approach to These Tumours | Geoffrey Rose (UK) | |
11:55-12:05 | Five Concepts of Periocular Non-Hodgkin Lymphoma | Jurij R Bilyk (USA) | |
12:05-12:15 | Management of Orbital Perineural Spread of SCC | Dinesh Selva (Australia) | |
12:15-12:25 | Optic Pathway Gliomas: A Non-neurosurgical Approach to Debulking Alone | William R Katowitz (USA) | |
12:25-12:35 | Enlarged One Muscle: What Should We Know? | Kyung In Woo (Korea) | |
12:35-12:45 | Malignant Lacrimal Sac Tumors: Diagnosis and Management | Chieh-Chih Tsai (Taiwan) | |
12:45-13:00 | DISCUSSION | ||
13:00-14:00 | LUNCH |
14:00-15:40 | Lacrimal Gland Malignancy |
|
14:00-14:07 | Lacrimal Gland Pleomorphic Adenoma and Malignant Epithelial Tumours: Clinical and Imaging Differences | Stephanie Ming Young (Singapore) | |
14:07-14:17 | Pathology of Unusual Malignant Lacrimal Gland Tumors | Steffen Heegaard (Denmark) | |
14:17-14:27 | Considerations for the Treatment of Carcinoma Ex-Pleomorphic Adenoma | James A Garrity (USA) | |
14:27-14:37 | Bascom Palmer Experience with Lacrimal Gland Adenoid Cystic Carcinoma | Wendy Lee (USA) | |
14:37-14:44 | Lacrimal Gland Carcinoma : Why Exenteration Does Not Appear to Improve the Outcome | Geoffrey Rose (UK) | |
14:44-14:54 | Particle Therapy for Adenoid-Cystic Carcinoma of the Lacrimal Gland. Outcome Comparison Between Neutron-, Proton, and Carbon Ion-Therapy. | Eugen B Hug (Austria) | |
14:54-15:24 | Eye-preserving Combined-Modality Treatment for Adenoid Cystic Carcinoma of the Lacrimal Gland | Norbert Liebsch (USA) | |
15:24-15:40 | DISCUSSION | ||
15:40-16:00 | BREAK |
16:00-17:20 | Challenges and Future in the Management of Orbital Diseases |
|
16:00-16:10 | Endoscopic Removal of Small Optic Apical Cavernous Hemangioma | Wencan Wu (China) | |
16:10-16:20 | 360 Degree Circumferential Endoscopic Approaches to the Orbital Apex Lesions | Doo Sik Kong (Korea) | |
16:20-16:30 | Gamma Knife Radiosurgery for Orbital Apical Lesions | Ho Jun Seol (Korea) | |
16:30-16:40 | Orbital Magnets for Intractable Nystagmus: World First | David Verity (UK) | |
16:40-16:52 | Targeted Therapies in Orbital Disease | Timothy Sullivan (Australia) | |
16:52-17:02 | The Use of Immunotherapy for Locally Advanced Orbital and Adnexal Cancers | Bita Esmaeli (USA) | |
17:02-17:20 | DISCUSSION |